295 related articles for article (PubMed ID: 34040906)
21. The minimum standard of care for managing malignant pleural mesothelioma in developing nations within the Asia-Pacific Region.
Ke H; Kao S; Lee K; Takahashi K; Goh HP; Linton A
Asia Pac J Clin Oncol; 2022 Jun; 18(3):177-190. PubMed ID: 34161674
[TBL] [Abstract][Full Text] [Related]
22. [Malignant pleural mesothelioma in patients hospitalised at the Clinical Hospital Centre Rijeka between 1989 and 2008].
Kricka O; Matanić Lender D; Barković I; Flego V; Kupanovac Z; Bulat Kardum L
Arh Hig Rada Toksikol; 2009 Nov; 60 Suppl():41-3. PubMed ID: 20853777
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology and outcome of peritoneal and pleural mesothelioma subtypes in Norway. A 20 year nation-wide study.
Brustugun OT; Nilssen Y; Eide IJZ
Acta Oncol; 2021 Oct; 60(10):1250-1256. PubMed ID: 34313510
[TBL] [Abstract][Full Text] [Related]
24. Time trend of mesothelioma incidence in the United States and projection of future cases: an update based on SEER data for 1973 through 2005.
Price B; Ware A
Crit Rev Toxicol; 2009; 39(7):576-88. PubMed ID: 19650718
[TBL] [Abstract][Full Text] [Related]
25. Non-asbestos-related malignant pleural mesothelioma.
Kanbay A; Ozer Simsek Z; Tutar N; Yılmaz I; Buyukoglan H; Canoz O; Demir R
Intern Med; 2014; 53(17):1977-9. PubMed ID: 25175133
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology of pleural mesothelioma in a population with non-occupational asbestos exposure.
Metintas M; Metintas S; Ak G; Erginel S; Alatas F; Kurt E; Ucgun I; Yildirim H
Respirology; 2008 Jan; 13(1):117-21. PubMed ID: 18197921
[TBL] [Abstract][Full Text] [Related]
27. Incidence and survival trends for malignant pleural and peritoneal mesothelioma, Australia, 1982-2009.
Soeberg MJ; Leigh J; Driscoll T; Armstrong B; Young JM; van Zandwijk N
Occup Environ Med; 2016 Mar; 73(3):187-94. PubMed ID: 26800709
[TBL] [Abstract][Full Text] [Related]
28. CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure.
Kettunen E; Savukoski S; Salmenkivi K; Böhling T; Vanhala E; Kuosma E; Anttila S; Wolff H
BMC Cancer; 2019 May; 19(1):507. PubMed ID: 31138176
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology of mesothelioma of the pericardium and tunica vaginalis testis.
Mezei G; Chang ET; Mowat FS; Moolgavkar SH
Ann Epidemiol; 2017 May; 27(5):348-359.e11. PubMed ID: 28527639
[TBL] [Abstract][Full Text] [Related]
30. Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects.
Guarrera S; Viberti C; Cugliari G; Allione A; Casalone E; Betti M; Ferrante D; Aspesi A; Casadio C; Grosso F; Libener R; Piccolini E; Mirabelli D; Dianzani I; Magnani C; Matullo G
J Thorac Oncol; 2019 Mar; 14(3):527-539. PubMed ID: 30408567
[TBL] [Abstract][Full Text] [Related]
31. CT findings in malignant pleural mesothelioma related to nonoccupational exposure to asbestos and fibrous zeolite (erionite).
Erzen C; Eryilmaz M; Kalyoncu F; Bilir N; Sahin A; Baris YI
J Comput Assist Tomogr; 1991; 15(2):256-60. PubMed ID: 1848247
[TBL] [Abstract][Full Text] [Related]
32. Epidemiology of mesothelioma in Egypt. A ten-year (1998-2007) multicentre study.
Akl Y; Kaddah S; Abdelhafeez A; Salah R; Lotayef M
Arch Med Sci; 2010 Dec; 6(6):926-31. PubMed ID: 22427768
[TBL] [Abstract][Full Text] [Related]
33. Increased Standardised Incidence Ratio of Malignant Pleural Mesothelioma in Taiwanese Asbestos Workers: A 29-Year Retrospective Cohort Study.
Lin CK; Chang YY; Wang JD; Lee LJ
Biomed Res Int; 2015; 2015():678598. PubMed ID: 26290869
[TBL] [Abstract][Full Text] [Related]
34. Transcriptomic Analysis of the Claudin Interactome in Malignant Pleural Mesothelioma: Evaluation of the Effect of Disease Phenotype, Asbestos Exposure, and CDKN2A Deletion Status.
Rouka E; Vavougios GD; Solenov EI; Gourgoulianis KI; Hatzoglou C; Zarogiannis SG
Front Physiol; 2017; 8():156. PubMed ID: 28377727
[TBL] [Abstract][Full Text] [Related]
35. Malignant pleural mesothelioma and mesothelial hyperplasia: A new molecular tool for the differential diagnosis.
Bruno R; Alì G; Giannini R; Proietti A; Lucchi M; Chella A; Melfi F; Mussi A; Fontanini G
Oncotarget; 2017 Jan; 8(2):2758-2770. PubMed ID: 27835874
[TBL] [Abstract][Full Text] [Related]
36. Critical role of the Ror-family of receptor tyrosine kinases in invasion and proliferation of malignant pleural mesothelioma cells.
Saji T; Nishita M; Ogawa H; Doi T; Sakai Y; Maniwa Y; Minami Y
Genes Cells; 2018 Jul; 23(7):606-613. PubMed ID: 29845703
[TBL] [Abstract][Full Text] [Related]
37. Geographic and socioeconomic factors in patients with malignant pleural mesothelioma in New South Wales and their impact upon clinical outcomes.
Linton A; Soeberg M; Broome R; Kao S; van Zandwijk N
Respirology; 2017 Jul; 22(5):978-985. PubMed ID: 28139858
[TBL] [Abstract][Full Text] [Related]
38. Epidemiologic surveillance of mesothelioma in Umbria.
Petrucci MS; De Lio MC; D'Alò D; Stracci F; Masanotti GM
Ann Ig; 2015; 27(3):526-32. PubMed ID: 26152538
[TBL] [Abstract][Full Text] [Related]
39. Incidence patterns for primary malignant spinal cord gliomas: a Surveillance, Epidemiology, and End Results study.
Hsu S; Quattrone M; Ostrom Q; Ryken TC; Sloan AE; Barnholtz-Sloan JS
J Neurosurg Spine; 2011 Jun; 14(6):742-7. PubMed ID: 21395394
[TBL] [Abstract][Full Text] [Related]
40. Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers.
Bononi I; Comar M; Puozzo A; Stendardo M; Boschetto P; Orecchia S; Libener R; Guaschino R; Pietrobon S; Ferracin M; Negrini M; Martini F; Bovenzi M; Tognon M
Oncotarget; 2016 Dec; 7(50):82700-82711. PubMed ID: 27716620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
